Main Article Content
Abstract
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124(10): 1501-1512. DOI: 10.1111/1471-0528.14640
Chiaffarino F, Cipriani S, Ricci E, La Vecchia C, Chiantera V, Bulfoni A, Parazzini F. Alcohol consumption and risk of uterine myoma: A systematic review and meta-analysis. PLoS One. 2017; 12(11): e0188355. DOI: 10.1371/journal.pone.0188355
Sandberg EM, Tummers FHMP, Cohen SL, van den Haak L, Dekkers OM, Jansen FW. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018; 109(4): 698-707.e1. DOI: 10.1016/j.fertnstert.2017.11.033
Czuczwar P, Stepniak A, Milart P, Paszkowski T, Wozniak S. Comparison of the influence of three fibroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve – an observational study. J Ovarian Res. 2018; 11(1): 45. DOI: 10.1186/s13048-018-0420-1
Wang X, Chen L, Wang H, Li Q, Liu X, Qi H. The Impact of Noncavity-Distorting Intramural Fibroids on the Efficacy of In Vitro Fertilization-Embryo Transfer: An Updated Meta-Analysis. Biomed Res Int. 2018; 2018: 8924703. DOI: 10.1155/2018/8924703
Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018; 143(3): 393-408. DOI: 10.1002/ijgo.12666
El-Balat A, DeWilde RL, Schmeil I, Tahmasbi-Rad M, Bogdanyova S, Fathi A, Becker S. Modern Myoma Treatment in the Last 20 Years: A Review of the Literature. Biomed Res Int. 2018; 2018: 4593875. DOI: 10.1155/2018/4593875
Kubik-Huch RA, Weston M, Nougaret S, Leonhardt H, Thomassin-Naggara I, Horta M, et al. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas. Eur Radiol. 2018; 28(8): 3125-3137. DOI: 10.1007/s00330-017-5157-5
Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: A review of the literature and update on management options. Gynecol Oncol. 2018; 151(3): 562-572. DOI: 10.1016/j.ygyno.2018.09.010
Bofill M. R. et al. Cyclical progestogens for heavy menstrual bleeding //The Cochrane database of systematic reviews. – 2019. – Т. 8.
Bofill Rodriguez M, Lethaby A, Low C, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019; 8(8): CD001016. DOI: 10.1002/14651858.CD001016.pub3
Yin X, Cheng J, Ansari SH, Campo R, Di W, Li W, Bigatti G. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis. Facts Views Vis Obgyn. 2018; 10(4): 207-213
Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L, et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol. 2019; 54(5): 676-687. DOI: 10.1002/uog.20270